March 3, 2026

Tenecteplase for Acute Non–Large Vessel Occlusion Ischemic Stroke

Puntos clave

Tenecteplase improves outcomes in patients with acute ischemic stroke caused by non-large vessel occlusions.
Key evidence shows that treatment was administered between 4.5 and 24 hours after symptom onset.
Observational analysis confirmed the presence of salvageable brain tissue in the patients treated.
Highlights the need for timely intervention to enhance recovery potential in specific stroke types.

Resumen

This study examined whether tenecteplase improves outcomes in patients with acute ischemic stroke caused by non–large vessel blockages (occlusions) and evidence of salvageable brain tissue when given between 4.5 and 24 hours after symptom onset.

Me gusta

Guardar

Cite This Study

A Thu, study studied this question.

synapsesocial.com/papers/69a766e3badf0bb9e87deccb https://doi.org/https://doi.org/10.1001/jama.2026.0263

Me gusta

Guardar